Clinical trial
Effectiveness of Atomoxetine in Treating ADHD Symptoms in Children and…
NCT00498173 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00498173 |
|---|---|
| Title | Effectiveness of Atomoxetine in Treating ADHD Symptoms in Children and Adolescents With Autism |
| Official title | Targeted Pharmacologic Interventions for Autism: A Double-Blind, Placebo-Controlled Trial of Atomoxetine in Children and Adolescents With Autism |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Autism |
| Intervention type | Drug |
| Interventions | Atomoxetine, Placebo |
| Enrollment | 60 |
| Start date | Jul 1, 2007 |
| Primary completion | Oct 1, 2015 |
| Completion | Oct 1, 2015 |
| First posted | Jul 9, 2007 |
| Last update posted | Nov 14, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: